2016-10-03T11:43:33-05:00 2015-12-31 951777440 GREEN HASSON & JANKS LLP 10990 WILSHIRE BLVD 16TH FLOOR LOS ANGELES CA 900243929 990 2015-01-01 261636099 MELANOMA RESEARCH ALLIANCE FOUNDATION MELA 2023368935 1101 NEW YORK AVE NW NO 620 WASHINGTON DC 20005 MICHAEL KAPLAN PRESIDENT/CEO 2023368935 2016-09-22 1 LAUREN A HAVERLOCK P00545829 3108731600 2015 2017-02-10 21:41:12Z MICHAEL KAPLAN 1101 NEW YORK AVE NW NO 620 WASHINGTON DC 20005 12239194 0 X WWW.MELANOMARESEARCHALLIANCE.ORG X 2007 DE TO ACCELERATE SCIENTIFIC DISCOVERY TO ELIMINATE SUFFERING AND DEATH DUE TO MELANOMA 22 21 17 50 0 0 7666134 11318796 0 0 38164 48679 147143 -2321 7851441 11365154 9879193 7834570 0 0 1258958 1410354 0 0 688421 987355 1198251 12125506 10443175 -4274065 921979 31243552 32895194 291629 1021292 30951923 31873902 X TO END SUFFERING AND DEATH DUE TO MELANOMA BY COLLABORATING WITH ALL STAKEHOLDERS TO ACCELERATE POWERFUL RESEARCH, ADVANCE CURES FOR ALL PATIENTS, AND PREVENT MORE MELANOMAS. 0 0 9302376 7834570 THE MELANOMA RESEARCH ALLIANCE FOUNDATION ("MRA") SUPPORTS AMBITIOUS AND INNOVATIVE PROJECTS, INITIATED BY INDIVIDUAL SCIENTISTS AND SCIENCE RESEARCH TEAMS, TO DEVELOP NOVEL DIAGNOSTIC AND THERAPEUTIC AVENUES RELEVANT TO PATHWAYS GOVERNING THE BEHAVIOR AND CLINICAL OUTCOME OF MELANOMA. MRA CONVENES A WORLD CLASS, CROSS-DISCIPLINARY GROUP OF EXPERT BIOMEDICAL RESEARCHERS POSSESSING CLINICAL AND SCIENTIFIC EXPERTISE TO DEVELOP A RESEARCH AGENDA THAT WILL PROVIDE INNOVATIVE SOLUTIONS TO CRITICAL RESEARCH ISSUES LEADING TO BETTER TREATMENTS AND A CURE FOR MELANOMA. MRA MAKES GRANTS TO DOMESTIC RESEARCH UNIVERSITIES, MEDICAL SCHOOLS, AND NONPROFIT MEDICAL RESEARCH ORGANIZATIONS DIRECTLY INVOLVED IN DETERMINING THE CAUSES AND CURES OF MELANOMA ON THE CONDITION THAT SUCH RESEARCH BE MADE AVAILABLE TO THE SCIENTIFIC COMMUNITY. MRA ALSO MAKES GRANTS TO FOREIGN RESEARCH UNIVERSITIES, MEDICAL SCHOOLS AND MEDICAL RESEARCH ORGANIZATIONS. 9302376 1 1 0 1 0 0 0 0 0 0 1 0 0 0 1 0 1 1 0 0 1 1 0 0 1 0 0 1 0 1 0 0 0 0 0 0 0 0 1 0 0 0 0 1 0 0 0 1 X 14 0 1 17 1 0 0 0 0 0 1 1 0 0 0 0 X 22 21 1 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 0 0 AL AK AZ AR CA CO CT FL GA HI IL KS KY MA MD ME MI MN NH NJ NM NY NC ND PA OR OK OH RI SC TN UT VA WA WI WV X X MICHAEL KAPLAN 2023368935 1101 NEW YORK AVE NW 620 WASHINGTON DC 20005 DEBRA BLACK CHAIR/CO-FOUNDER 10.00 X X 0 0 0 LEON BLACK DIRECTOR/CO-FOUNDER 0.30 X 0 0 0 MARIA BELL DIRECTOR 0.30 X 0 0 0 ELLEN DAVIS DIRECTOR 0.30 X 0 0 0 JASON FEDERICI DIRECTOR 0.30 X 0 0 0 JAMI GERTZ DIRECTOR 0.30 X 0 0 0 SUSAN HESS DIRECTOR 0.30 X 0 0 0 MICHAEL KLOWDEN DIRECTOR 0.30 40.00 X 0 547694 26468 AMANDA ELLIAN DIRECTOR 0.30 X 0 0 0 NANCY MARKS DIRECTOR 0.30 X 0 0 0 CINDY MCCAIN DIRECTOR 0.30 X 0 0 0 MICHAEL MILKEN DIRECTOR 0.30 X 0 0 0 RICHARD RESSLER DIRECTOR 0.30 X 0 0 0 JEFFREY ROWBOTTOM DIRECTOR 0.30 X 0 0 0 ELLIOTT SIGAL DIRECTOR 0.30 X 0 0 0 GREGORY SIMON DIRECTOR 0.30 X 0 0 0 JONATHAN SIMONS DIRECTOR 0.30 X 0 0 0 JONATHAN SOKOLOFF DIRECTOR 0.30 X 0 0 0 ELIZABETH STANTON DIRECTOR 0.30 X 0 0 0 SUZANNE TOPALIAN DIRECTOR 5.00 X 0 0 0 DAISY HELMAN DIRECTOR 0.30 X 0 0 0 MARY JO ROGERS DIRECTOR 0.30 X 0 0 0 WENDY SELIG THROUGH 063015 PRESIDENT & CEO 40.00 X 226298 0 14655 MARGARET ANDERSON FROM 0715 INTERIM PRESIDENT & CEO 5.00 X 0 368052 24090 ROBIN DAVISSON FROM 11215 PRESIDENT & CEO 10.00 X 12500 0 0 KAMYAB HASHEMI-NEJAD TREASURER 10.00 40.00 X 0 183875 26436 LOUISE PERKINS CHIEF SCIENCE OFFICER 40.00 X 289223 0 16424 LAURA BROCKWAY-LUNARDI SCIENTIFIC PROGRAM DIRECTOR 40.00 X 113936 0 30634 LOGAN KASTNER DIRECTOR, MKTG & DEVELOPMENT 40.00 X 105591 0 16741 747548 1099621 155448 4 0 1 0 THE ALEXANDER GROUP 2700 POST OAK BLVD SUITE 2400 HOUSTON TX 77056 RECRUITING 125292 1 6942925 4375871 1034861 11318796 48679 48679 863300 6942925 874040 -10740 -10740 OTHER INCOME 900099 8419 8419 8419 11365154 0 0 46358 6277725 6277725 1556845 1556845 253453 101381 50691 101381 975686 473703 213677 288306 106637 52780 22438 31419 74578 36543 16407 21628 3899 1658 745 1496 20250 20250 172266 93619 33926 44721 58566 35706 8611 14249 44706 28627 6145 9934 142767 95418 18506 28843 156201 76828 32725 46648 315348 232225 9044 74079 211159 203523 3143 4493 21892 10727 4816 6349 15628 7658 3438 4532 CREDIT CARD PROCESSING 22409 10981 4930 6498 STATE FILING FEES 13160 6429 2886 3845 10443175 9302376 452378 688421 1339596 3424292 14877111 18777790 14958422 10620521 36673 43037 101179 71879 30836 29300 914 254 31243552 32895194 139129 714723 152500 265000 0 41569 291629 1021292 X 12920141 17015455 18031782 14858447 30951923 31873902 31243552 32895194 921979 0 X 0 1 X 1 0 X X X 1 THE MILKEN INSTITUTE 954240775 7 1 7834570 0 1 7834570 0 1 0 0 0 0 1 0 0 0 0 0 0 0 0 0 1 0 PART IV, SECTION A, LINE 6 THE AMOUNT OF SUPPORT REPORTED TO MILKEN INSTITUTE REPRESENTS THE AMOUNT OF FUNDS THAT MRA PAYS DIRECTLY TO RESEARCH ORGANIZATIONS LISTED ON SCHEDULES F AND I THAT SUPPORT MELANOMA RESEARCH THAT ADVANCES THE MISSION OF BOTH MRA AND THE MILKEN INSTITUTE. MRA PROVIDES DIRECT SUPPORT TO PUBLIC CHARITIES AND EDUCATIONAL INSTITUTIONS FOR THE PURPOSES OF CANCER RESEARCH SPECIFICALLY RELATED TO MELANOMA. SUPPORTING THESE UNRELATED RESEARCH ORGANIZATIONS DIRECTLY SUPPORTS THE MISSION OF THE MILKEN INSTITUTE SINCE PART OF THE INSTITUTE'S MISSION IS TO IMPROVE HEALTH WORLDWIDE. BY MRA PROVIDING THE GRANTS DIRECTLY TO THE CHARITIES AND EDUCATIONAL INSTITUTIONS, IT FURTHER ASSISTS THE MILKEN INSTITUTE. BECAUSE THERE IS A DIRECT LINE OF COMMUNICATION BETWEEN DONOR AND GRANT RECIPIENT, THE INSTITUTE CAN RELY ON MRA TO PROVIDE GRANT MONITORING AND GRANT SUPPORT SERVICES TO GRANT RECIPIENTS. RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 1000 1000 9994613 9995613 649781 162445 0 0 594761 670199 738010 649781 2652751 3979127 2500 4200 18000 1000 25700 148690 167550 184503 162445 663188 994782 101179 71879 29300 29300 DUE TO AFFILIATE 41569 41569 11365799 645 645 11365154 0 11365154 10443820 645 645 10443175 0 10443175 1 MIDDLE EAST AND NORTH AFRICA 0 0 GRANTS TO RECIPIENTS LOCATED IN THE REGION 1031845 EAST ASIA AND THE PACIFIC 0 0 GRANTS TO RECIPIENTS LOCATED IN THE REGION 112500 EUROPE (INCLUDING ICELAND & GREENLAND) 0 0 GRANTS TO RECIPIENTS LOCATED IN THE REGION 412500 0 0 0 0 0 0 1556845 0 1556845 MIDDLE EAST AND NORTH AFRICA TEAM SCIENCE AWARD 394345 WIRE MIDDLE EAST AND NORTH AFRICA TEAM SCIENCE AWARD 300000 CHECK MIDDLE EAST AND NORTH AFRICA TEAM SCIENCE AWARD 225000 CHECK EUROPE (INCLUDING ICELAND & GREENLAND) TEAM SCIENCE AWARD/ESTABLISHED INVESTIGATOR AWARD 412500 WIRE MIDDLE EAST AND NORTH AFRICA ESTABLISHED INVESTIGATOR AWARD 112500 WIRE EAST ASIA AND THE PACIFIC ESTABLISHED INVESTIGATOR AWARD 112500 WIRE 6 0 0 0 0 0 0 PART I, LINE 2: EACH PROPOSAL TO THE MRA IS REVIEWED FOR SCIENTIFIC MERIT AND TRANSLATIONAL AND CLINICAL IMPACT BY MRA'S WORLD-CLASS GRANT REVIEW COMMITTEE (GRC). CRITERIA ARE DESCRIBED IN THE MRA'S REQUEST FOR PROPOSALS. GRC MEMBERS ARE SENIOR THOUGHT-LEADERS IN MELANOMA AND CANCER RESEARCH. AFTER SCIENTIFIC PEER REVIEW BY THE GRC, THE MRA BOARD OF DIRECTORS APPROVES FINAL RESEARCH AWARDS FOR FUNDING. RESEARCH AWARD FUNDS ARE DISPENSED ON AN ANNUAL BASIS, CONTINGENT UPON MRA STAFF REVIEW OF ANNUAL PROGRESS REPORTS SUBMITTED BY THE GRANTEES. PART I, LINE 3: AWARDEES PROVIDE MRA WITH ANNUAL WRITTEN REPORTS OF THEIR RESEARCH PROGRESS AND COMPLIANCE WITH BUDGET GUIDELINES. FUNDS ARE DISTRIBUTED IN ANNUAL INSTALLMENTS AND NEXT YEAR'S INSTALLMENT IS NOT PROVIDED UNTIL SATISFACTORY REVIEW BY THE MRA CHIEF SCIENCE OFFICER AND SCIENTIFIC PROGRAM DIRECTOR. AWARDEES MUST KEEP SYSTEMATIC AND COMPLETE RECORDS ON THE RECEIPT AND DISBURSEMENT OF ALL AWARD FUNDS, AND MAY NOT COMMINGLE ANY FUNDS FROM OTHER SOURCES. LEVEREDGED FINANCE 1598714 1530314 68400 27436 123000 94796 BENEFITS DINNER 6207511 5412611 794900 26758 36440 565610 7806225 6942925 863300 54194 159440 660406 874040 -10740 1 BAYLOR COLLEGE OF MEDICINE ONE BAYLOR PLAZA R407 HOUSTON TX 77030 741613878 501(C)(3) 75000 YOUNG INVESTIGATOR AWARD BRIGHAM AND WOMEN'S HOSPITAL INC 75 FRANCIS STREET BOSTON MA 02115 042312909 501(C)(3) 175000 YOUNG INVESTIGATOR AWARD DANA-FARBER CANCER INSTITUTE 450 BROOKLINE AVENUE D1542 BOSTON MA 02215 042263040 501(C)(3) 425000 YOUNG INVESTIGATOR AWARD, INDUSTRY PARTNERSHIP AWARD, AND TEAM SCIENCE AWARD DUKE UNIVERSITY 230 RESEARCH DRIVE MSR81 DURHAM NC 27710 560532129 501(C)(3) 25000 YOUNG INVESTIGATOR AWARD FRED HUTCHINSON CANCER RESEARCH CENTER 1100 FAIRVIEW AVENUE N J6-500 PO BOX 19024 SEATTLE WA 98109 237156071 501(C)(3) 173073 YOUNG INVESTIGATOR AWARD ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI 1 GUSTAVE L LEVY PLACE NEW YORK NY 10029 136171197 501(C)(3) 37500 ESTABLISHED INVESTIGATOR JOAN & SANFORD I WEILL MEDICAL COLLEGE OF CORNELL UNIVERSITY 413 EAST 69TH ST 13TH FLOOR BOX 50 NEW YORK NY 10021 131623978 501(C)(3) 150000 TEAM SCIENCE AWARD JOHNS HOPKINS UNIVERSITY 1650 ORLEANS ST CRB1 RM 452 BALTIMORE MD 21287 520595110 501(C)(3) 120000 ACADEMIC- INDUSTRY PARTNERSHIP AWARD AND TEAM SCIENCE AWARD KAISER FOUNDATION DIVISION OF RESEARCH 2000 BROADWAY 3RD FL OAKLAND CA 94612 941340523 501(C)(3) 82090 TEAM SCIENCE AWARD LA JOLLA INSTITUTE FOR A&I 9420 ATHENA CIRCLE LA JOLLA CA 92037 330328688 501(C)(3) 75000 YOUNG INVESTIGATOR AWARD MASSACHUSETTS GENERAL HOSPITAL CUTANEOUS BIOLOGY RESEARCH CENTER BUILDING 149 3RD FLOOR CHARLESTOWN MA 02129 042697983 501(C)(3) 692910 TEAM SCIENCE AWARD AND YOUNG INVESTIGATOR AWARD MASSACHUSETTS INSTITUTE OF TECHNOLOGY 77 MASSACHUSETTS AVENUE CAMBRIDGE MA 02139 042103594 501(C)(3) 362500 TEAM SCIENCE AWARD AND ESTABLISHED INVESTIGATOR AWARD MEMORIAL SLOAN-KETTERING CANCER CENTER 44 BINNEY STREET BOSTON MA 02115 131924236 501(C)(3) 962500 ESTABLISHED INVESTIGATOR AWARD, ACADEMIC INDUSTRY PARTNERSHIP AWARD, TEAM SCIENCE AWARD, AND YOUNG INVESTIGATOR AWARD NEW YORK UNIVERSITY 546 FIRST AVENUE NEW YORK NY 10016 136562308 501(C)(3) 37500 ESTABLISHED INVESTIGATOR NORTHWESTERN UNIVERSITY - CHICAGO CAMPUS 300 E SUPERIOR STREET TARRY 13-705 CHICAGO IL 60611 362167817 501(C)(3) 50000 PILOT AWARD THE OHIO STATE UNIVERSITY 1960 KENNY ROAD COLUMBUS OH 43210 316025986 PUBLIC UNIVERSITY 37500 YOUNG INVESTIGATOR AWARD THE REGENTS OF THE UNIVERSITY OF CALIFORNIA IRVINE 845 HEALTH SERVICES ROAD SUITE 3022 3022 IRVINE CA 92697 952226406 PUBLIC UNIVERSITY 75000 YOUNG INVESTIGATOR AWARD THE REGENTS OF THE UNIVERSITY OF CALIFORNIA LOS ANGELES UCLA SCHOOL OF MEDICINE 52-121 CHS DEPT OF MEDICINE/DERMATOLOGY 10833 LOS ANGELES CA 900951770 943067788 PUBLIC UNIVERSITY 375000 TEAM SCIENCE AWARD AND YOUNG INVESTIGATOR AWARD THE REGENTS OF THE UNIVERSITY OF CALIFORNIA SAN FRANCISCO 1450 3RD ST HD-365 HELEN DILLER CR BLDG SAN FRANCISCO CA 941430128 946036493 PUBLIC UNIVERSITY 246126 ESTABLISHED INVESTIGATOR AWARD, ESTABLISHED INVESTIGATOR PARTNERSHIP AWARD, AND YOUNG INVESTIGATOR AWARD THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK 615 WEST 131ST STREET 3RD FLOOR NEW YORK NY 10027 135598093 501(C)(3) 33000 ACADEMIC INDUSTRY PARTNERSHIP AWARD THOMAS JEFFERSON UNIVERSITY 233 SOUTH 10TH STREET PHILADELPHIA PA 19107 231352651 501(C)(3) 83333 ESTABLISHED INVESTIGATOR PATNERSHIP AWARD TRUSTEES OF BOSTON UNIVERSITY 881 COMMONWEALTH AVENUE BOSTON MA 02215 042103547 501(C)(3) 250000 YOUNG INVESTIGATOR AWARD AND ESTABLISHED INVESTIGATOR AWARD THE WISTAR INSTITUTE 3601 SPRUCE STREET PHILADELPHIA PA 19104 236227265 501(C)(3) 325000 TEAM SCIENCE AWARD AND YOUNG INVESTIGATOR AWARD UNIVERSITY OF CHICAGO 5841 S MARYLAND AVE MC2115 CHICAGO IL 60637 362177139 501(C)(3) 300000 TEAM SCIENCE AWARD UNIVERSITY OF CINCINNATI 3225 EDEN AVENUE 225C WHERRY HALL CINCINNATI OH 45221 316000989 PUBLIC UNIVERSITY 20000 YOUNG INVESTIGATOR AWARD UNIVERSITY OF HOUSTON 4800 CALHOUN 316 E CULLEN BLDG HOUSTON TX 77204 746001399 PUBLIC UNIVERSITY 75000 YOUNG INVESTIGATOR AWARD UNIVERSITY OF KENTUCKY MARKEY CANCER FOUNDATION 800 ROSE STREET COMBS 204 LEXINGTON KY 40536 310944925 501(C)(3) 87500 ESTABLISHED INVESTIGATOR UNIVERSITY OF NC- CHAPEL HILL 120 MASON FARM RD 4016 GENETIC MEDICINE BLDG CHAPEL HILL NC 275997365 566001393 PUBLIC UNIVERSITY 77193 INDUSTRIAL PARTNERSHIP AWARD UNIVERSITY OF MARYLAND FOUNDATION INC 3300 METZAROTT ROAD ADELPHI MD 20783 521125883 501(C)(3) 25000 YOUNG INVESTIGATOR AWARD UNIVERSITY OF MICHIGAN 3003 S STATE STREET ANN ARBOR MI 481091274 386006309 501(C)(3) 75000 YOUNG INVESTIGATOR AWARD TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA 3451 WALNUT STREET PHILADELPHIA PA 19104 231352685 501(C)(3) 75000 YOUNG INVESTIGATOR AWARD UNIVERSITY OF PITTSBURGH 5117 CENTRE AVENUE PITTSBURGH PA 15213 250965591 501(C)(3) 100000 MRA ACADEMIC-INDUSTRY PARTNERSHIP AWARD UNIVERSITY OF SOUTH CAROLINA 1600 HAMPTON STREET 6TH FLOOR COLUMBIA SC 29208 575001153 501(C)(3) 125000 PILOT AWARD AND YOUNG INVESTIGATOR AWARD UNIVERSITY OF UTAH 201 S PRESIDENTS CIRCLE ROOM 411 SALT LAKE CITY UT 84112 876000525 501(C)(3) 112500 ESTABLISHED INVESTIGATOR AWARD UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER 1515 HOLCOMBE BLVD UNIT 0904 HOUSTON TX 77030 746001118 PUBLIC UNIVERSITY 75000 YOUNG INVESTIGATOR AWARD WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH 9 CAMBRIDGE CENTER CAMBRIDGE MA 02142 061043412 501(C)(3) 25000 YOUNG INVESTIGATOR AWARD YALE UNIVERSITY 47 COLLEGE STREET SUITE 203 NEW HAVEN CT 06520 060646973 501(C)(3) 237500 PILOT AWARD AND YOUNG INVESTIGATOR AWARD 38 PART I, LINE 2: EACH PROPOSAL TO THE MRA IS REVIEWED FOR SCIENTIFIC MERIT AND TRANSLATIONAL AND CLINICAL IMPACT BY MRA'S WORLD-CLASS GRANT REVIEW COMMITTEE (GRC). CRITERIA ARE DESCRIBED IN THE MRA'S REQUEST FOR PROPOSALS. GRC MEMBERS ARE SENIOR THOUGHT-LEADERS IN MELANOMA AND CANCER RESEARCH. AFTER SCIENTIFIC PEER REVIEW BY THE GRC, THE MRA BOARD OF DIRECTORS APPROVES FINAL RESEARCH AWARDS FOR FUNDING. RESEARCH AWARD FUNDS ARE DISPENSED ON AN ANNUAL BASIS, CONTINGENT UPON MRA STAFF REVIEW OF ANNUAL PROGRESS REPORTS SUBMITTED BY THE GRANTEES. ALL MRA-FUNDED INVESTIGATORS AND THEIR INSTITUTIONS MUST AGREE TO PERFORM THE RESEARCH PROPOSAL IN FULL COMPLIANCE WITH ALL APPLICABLE LAWS AND REGULATIONS, THE TERMS AND CONDITIONS OF THE MRA REQUEST FOR PROPOSALS, THE REQUIREMENTS OF THE MRA TERMS AND CONDITIONS OF THE RESEARCH PROPOSAL. AT ANY TIME DURING THE AWARD PERIOD, AWARDEES MUST NOTIFY AND MRA MUST APPROVE ANY SIGNIFICANT CHANGES TO THE RESEARCH PROPOSAL INCLUDING RESEARCH PLAN, BUDGET, AND PERSONNEL. AWARDEES PROVIDE MRA WITH ANNUAL WRITTEN REPORTS OF THEIR RESEARCH PROGRESS AND COMPLIANCE WITH BUDGET GUIDELINES. FUNDS ARE DISTRIBUTED IN ANNUAL INSTALLMENTS AND NEXT YEAR'S INSTALLMENT IS NOT PROVIDED UNTIL SATISFACTORY REVIEW BY THE MRA CHIEF SCIENCE OFFICER AND SCIENTIFIC PROGRAM DIRECTOR. AWARDEES MUST KEEP SYSTEMATIC AND COMPLETE RECORDS ON THE RECEIPT AND DISBURSEMENT OF ALL AWARD FUNDS, AND MAY NOT CO-MINGLE ANY FUNDS FROM OTHER SOURCES. X X X 1 0 0 0 0 0 0 1 0 MICHAEL KLOWDEN DIRECTOR 0 447694 0 100000 0 0 0 5300 0 21168 0 574162 0 0 WENDY SELIG THROUGH 063015 PRESIDENT & CEO 176298 0 0 0 50000 0 0 0 14655 0 240953 0 0 0 MARGARET ANDERSON FROM 0715 INTERIM PRESIDENT & CEO 0 318052 0 50000 0 0 0 5300 0 18790 0 392142 0 0 KAMYAB HASHEMI-NEJAD TREASURER 0 178875 0 5000 0 0 0 3720 0 22716 0 210311 0 0 LOUISE PERKINS CHIEF SCIENCE OFFICER 274223 0 15000 0 0 0 5300 0 11124 0 305647 0 0 0 PART I, LINE 3 MARGARET ANDERSON, INERIM PRESIDENT AND CEO WAS COMPENSATED BY THE RELATED ORGANIZATION, THE MILKEN INSTITUTE. THE CEO OF MILKEN INSTITUTE ANNUALLY PROVIDES THE COMPENSATION COMMITTEE OF THE BOARD OF DIRECTORS A DETAILED REPORT OF ALL COMPENSATION ADJUSTMENTS, INCLUDING ADJUSTMENTS FOR THE OFFICERS AND SENIOR EMPLOYEES. PART I, LINE 4A WENDY SELIG, PRESIDENT AND CEO RECEIVED A SEVERANCE PAYMENT OF $50,000. PART I, LINE 7 EMPLOYEES WERE ELIGABLE TO RECEIVE PERFORMANCE-BASED BONUSES. X 1 375000 FMV X 8230 FMV X 8 429853 PROCEEDS (SEC SALES) X JEWELRY 1 150000 FMV X GIFT BAGS/TOTES 1 47000 FMV X MISC. ITEMS 5 12978 FMV X SHIRTS 1 11800 FMV 0 1 0 PART I, COLUMN (B): NON CASH DONATIONS ARE LISTED BY TOTAL NUMBER OF DONORS. FORM 990, PART V, LINE 2A THE ORGANIZATION DOES NOT ISSUE ANY W-2S FOR THEIR EMPLOYEES. THE SUPPORTED ORGANIZATION, THE MILKEN INSTITUTE, ISSUES ALL W-2S BUT EMPLOYEE COMPENSATION IS PAID BY THE MELANOMA RESEARCH ALLIANCE ITSELF. W-2S REPORTED ARE THOSE THAT ARE ISSUED BY MILKEN INSTITUTE ON BEHALF OF MRA. FORM 990, PART VI, SECTION A, LINE 2 DEBRA BLACK AND LEON BLACK HAVE A FAMILY RELATIONSHIP. DEBRA BLACK AND RICHARD RESSLER HAVE A FAMILY RELATIONSHIP. JAMI GERTZ AND DEBRA BLACK HAVE A FAMILY RELATIONSHIP. FORM 990, PART VI, SECTION B, LINE 11 MRA'S CEO AND TREASURER JOINTLY REVIEW THE FORM 990. THE FINAL DRAFT IS MADE AVAILABLE ELECTRONICALLY TO ALL THE BOARD MEMBERS BEFORE THE CEO SIGNS THE DOCUMENT AND IT IS FILED WITH THE IRS. FORM 990, PART VI, SECTION B, LINE 12C AS STATED IN THE MRA BYLAWS, EACH DIRECTOR, TRUSTEE, PRINCIPAL OFFICER, AND MEMBER OF A COMMITTEE OF THE BOARD IS TO SIGN A STATEMENT ANNUALLY AFFIRMING THEY HAVE RECEIVED THE CONFLICT OF INTEREST POLICY, THEY HAVE READ AND UNDERSTAND IT, AND THEY AGREE TO COMPLY WITH IT. UPON POTENTIAL CONFLICT OF INTERESTS, THE BOARD OR COMMITTEE WILL RESOLVE THE CONFLICT IN THE BEST INTEREST OF THE ORGANIZATION. FORM 990, PART VI, SECTION B, LINE 15A ACCORDING TO THE MRA BYLAWS, MEMBERS OF THE BOARD REVIEW AND APPROVE THE MRA CEO SALARY TO ENSURE IT IS JUST AND REASONABLE. DURING THIS ANNUAL REVIEW, MEMBERS OF THE BOARD USE THE FEDERAL FORM 990 OF OTHER ORGANIZATIONS FOR COMPARABLES. THERE ARE NO OTHER OFFICERS, DIRECTORS, OR KEY EMPLOYEES THAT ARE COMPENSATED BY MRA. FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION MAKES ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY AND FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC UPON REQUEST. A COPY OF THE FORM 990 AND THE FINANCIAL STATEMENTS ARE AVAILABLE ON THE ORGANIZATION'S WEBSITE. MILKEN INSTITUTE 1250 FOURTH STREET SANTA MONICA CA 90401 954240775 EDUCATIONAL, ECONOMIC RESEARCH, HEALTHCARE RESEARCH CA 501(C)(3) LINE 7 N/A 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 1 1 0 0 0